Search alternatives:
values decrease » values increased (Expand Search), largest decrease (Expand Search)
marked decrease » marked increase (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
3 n » 3 nm (Expand Search)
values decrease » values increased (Expand Search), largest decrease (Expand Search)
marked decrease » marked increase (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
3 n » 3 nm (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Changes in the active H3K27ac and repressive H3K27me3 histone marks among Vasa2+/Piwi1+ and all cells in fed, starved, and refed juvenile polyps.
Published 2025“…Significance levels after one-way ANOVA with Tukey’s HSD for pairwise comparisons are indicated for adjusted <i>p</i> values: *<i>p < </i>0.05, **<i>p < </i>0.01; ****<i>p < </i>0.0001. d: day(s), n.s.: non-significant. …”
-
12
-
13
-
14
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(n = 3–4). Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. …”
-
15
-
16
KAP assessment scores (n = 422).
Published 2025“…Attitude improved from 16.76 (93.1%) at baseline to 17.74 (98.6%) at the six-week mark. …”
-
17
-
18
-
19
-
20